Sun Pharmaceutical Industries announces unaudited standalone & consolidated results

14 Feb 2017 Evaluate

Sun Pharmaceutical Industries has announced the Unaudited Standalone results for the Quarter ended December 31, 2016. The Company has posted a net loss of Rs (1626.60) million for the quarter ended December 31, 2016 as compared to net loss of Rs (1422.70) million for the quarter ended December 31, 2015. Total Income has increased from Rs 19283.90 million for the quarter ended December 31, 2015 to Rs 20128.10 million for the quarter ended December 31, 2016. The company also announced the Unaudited Consolidated results for the Quarter ended December 31, 2016. The Group has posted a net profit after taxes, non-controlling interest and share of profit of associates & joint ventures of Rs 14718.20 million for the quarter ended December 31, 2016 as compared to Rs 15448.50 million for the quarter ended December 31, 2015. Total Income has increased from Rs 72952.00 million for the quarter ended December 31, 2015 to Rs 80348.10 million for the quarter ended December 31, 2016.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Inds. Share Price

1794.30 -12.60 (-0.70%)
12-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.30
Dr. Reddys Lab 1279.65
Cipla 1517.20
Zydus Lifesciences 929.05
Lupin 2114.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×